|Grant Affiliation:||Walker: bNabs after Infection and Immunization|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-12-21|
|Study Made Public:||2013-10-16|
ATRECA/Ragon Collaboration: High throughput mAb cloning, a proof of concept pilot
CAVD 402 is a monoclonal antibody screening study evaluating evolution from non-neutralizing to broadly neutralizing antibody responses in chronically infected individuals.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No non-integrated data is available for this study.